future timeline technology singularity humanity
 
Blog»

 

 

6th September 2019

AI creates new drug compounds in 21 days

Insilico Medicine reports the creation, via artifical intelligence, of six novel inhibitors of the DDR1 gene, a kinase target implicated in fibrosis and other diseases. The system, known as Generative Tensorial Reinforcement Learning (GENTRL), designed the new compounds in 21 days, with a lead candidate tested and showing positive results in mice.

 

AI artificial intelligence drugs design future timeline

 

Comments »

 

 

 
 

 

Comments

 

 

 

 

⇡  Back to top  ⇡